The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales
- 1 April 2001
- Vol. 19 (23-24) , 3076-3090
- https://doi.org/10.1016/s0264-410x(01)00044-5
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Comparison of a live attenuated and an inactivated varicella vaccine to boost the varicella-specific immune response in seropositive people 55 years of age and olderVaccine, 2000
- Herpes zoster and its complications in Italy: An observational surveyJournal of Infection, 1999
- Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect.The Journal of Infectious Diseases, 1998
- The Sequelae of Herpes ZosterArchives of internal medicine (1960), 1997
- PREVENTION OF HERPES ZOSTERInfectious Disease Clinics of North America, 1996
- The Protective Effect of Immunologic Boosting against Zoster: An Analysis in Leukemic Children Who Were Vaccinated against ChickenpoxThe Journal of Infectious Diseases, 1996
- Oral Acyclovir Therapy Accelerates Pain Resolution in Patients with Herpes Zoster: A Meta-analysis of Placebo-Controlled TrialsClinical Infectious Diseases, 1996
- Epidemiology, outcome and control of varicella-zoster infectionReviews in Medical Microbiology, 1993
- Serologic response and reactogenicity to booster immunization of healthy seropositive adults with live or inactivated varicella vaccineAntiviral Research, 1992
- Population-Based Study of Herpes Zoster and Its SequelaeMedicine, 1982